The Lancet
Издатель: Elsevier · ISSN 0140-6736 · 79 статей
- Bundibugyo vaccine trial begins
- Impossible Choices: A Physician's Guidance on High-Risk Pregnancy in a World Without Roe, David N Hackney. The MIT Press (2026), 208, US$29·95, ISBN: 9780262054706
- Anita Belman
- Super El Niño threatens a public health emergency in Africa
- North Korea's health revolution in its 2026 medical journals
- Global health: dying from failure or fulfilment?
- Women with obstetric fistula in Somalia deserve better
- Women with obstetric fistula in Somalia deserve better – Author's reply
- Safety and efficacy of the 0/1 h pathway for myocardial infarction in the emergency department: an international, pragmatic, stepped-wedge, cluster-randomised, controlled trial
- Performance of 0/1 h versus 0/3 h pathways in patients with suspected myocardial infarction: a systematic review and individual participant data meta-analysis of randomised controlled trials
- Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China
- The 2026 report of the Lancet Countdown on health and climate change: a decade of escalating health harms and a decisive moment for all
- Generalised eruptive histiocytosis mimicking lymphoma relapse in a patient with previous diffuse large B-cell lymphoma
- Efficacy and safety of efinopegdutide in adults with metabolic dysfunction-associated steatohepatitis and stage 2–3 fibrosis: a phase 2b, randomised, placebo-controlled study
- Cardiovascular outcomes with survodutide in adults with obesity at increased cardiovascular risk (SYNCHRONIZE-CVOT): a double-blind, randomised, placebo-controlled, phase 3 trial
- Efinopegdutide: a step towards precision in MASH therapy?
- A blended digital parenting intervention for the prevention of sexual violence, exploitative sex, and maltreatment of children at scale in Tanzania: a cluster-randomised, controlled trial
- A digital intervention to strengthening parenting in Tanzania
- Reframing disease elimination: an update from the Lancet Commission on chronic obstructive pulmonary disease
- Trevogrumab (anti-GDF8) with or without garetosmab (anti-activin A) for prevention of muscle loss during semaglutide-induced weight reduction in people with obesity (COURAGE): a two-part, phase 2, double-blind, placebo-controlled, randomised trial
- Lynch syndrome
- Lula's new term—safeguarding science, health, and the Amazon
- Emerging Shamonda virus: a new threat to pregnancy?
- Cangrelor for myocardial infarction-related cardiogenic shock
- Health and poverty: lessons from China
- Optimising late-line treatment administration in metastatic colorectal cancer: an even brighter SUNLIGHT
- Is chemotherapy still needed in all patients with mismatch repair-deficient advanced or recurrent endometrial cancer?
- The overlooked role of CMV in pneumonia in infants with HIV
- Empirical tuberculosis treatment in infants living with HIV: missed opportunities and ways to improve outcomes
- Beyond poverty eradication: what China's health and poverty alleviation experience means for global health